3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Phase 1
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Breast
1
Conditions
Carcinoma, Non-Small-Cell Lung
85
Neoplasm Metastasis
74
Colorectal Neoplasms
74
Neoplasms
72
Leukemia, Myeloid, Acute
62
Breast Neoplasms
54
Prostatic Neoplasms
47
Multiple Myeloma
47
Ovarian Neoplasms
42
Pancreatic Neoplasms
41
Squamous Cell Carcinoma of Head and Neck
38
Melanoma
36
Recurrence
33
Glioblastoma
33
Lung Neoplasms
31
Myelodysplastic Syndromes
30
Triple Negative Breast Neoplasms
29
Lymphoma, Non-Hodgkin
29
Advanced Solid Tumors
27
Endometrial Neoplasms
26
Stomach Neoplasms
24
Small Cell Lung Carcinoma
24
Carcinoma, Renal Cell
24
Precursor Cell Lymphoblastic Leukemia-Lymphoma
23
Brain Neoplasms
22
Carcinoma, Hepatocellular
21
Sarcoma
19
Lymphoma, B-Cell
19
Lymphoma, Large B-Cell, Diffuse
18
Esophageal Neoplasms
18
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Pancreatic Intraductal Neoplasms
×
30 days
×
Clear all
NCT07213791
2026-06-04
FiREBOLT
Eli Lilly and Company
Phase 1
Recruiting
241 enrolled